A loophole that allows generic drugmakers to avoid liability when patients experience side effects may be coming to an end thanks to a ruling in an antidepressant suicide lawsuit.
Drug companies, politicians and patient groups are clamoring for faster approval of drugs. But doing so could bring potentially harmful drugs to market.
A new study finds that many patient advocacy groups receive heavy funding from industry, creating a serious conflict of interest.
Episiotomies used to be a standard procedure with vaginal births. That’s changing as the procedure is seen as over-medicalization.
A recent trip by the author to Haiti demonstrates that not-for-profits and drug companies can work together to benefit health care in poor countries.
More than 400 pages of medical research, 11 hours of testimony and a blizzard in March. Welcome to my first FDA Advisory hearing!
The tragedy of DES began 60 years ago as pregnant women took the synthetic estrogen that had dangerous side effects. But lessons have been learned.